Impairment of gastric ulcer healing by alendronate, a nitrogen-containing bisphosphonate, in rats

Digestive Diseases and Sciences

Volumn 52, Issue 8, 2007, Pages 1879-1889

  Amagase, Kikuko ^a   Hayashi, Shusaku ^a   Nishikawa, Kaoru ^a   Aihara, Eitaro ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Alendronate; Angiogenesis; Gastric ulcer healing; Growth factors

Indexed keywords

ACETIC ACID; ALENDRONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BISPHOSPHONIC ACID DERIVATIVE; CYCLOOXYGENASE 2; INDOMETACIN; PROSTAGLANDIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; STOMACH ULCER; VASCULARIZATION; WOUND HEALING;

ACETIC ACID; ALENDRONATE; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLAST GROWTH FACTOR 2; GASTRIC ACID; GASTRIC MUCOSA; INDOMETHACIN; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 34347369542     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9769-5     Document Type: Article

References (38)

1. Lowe CE, Depew TW, Vanner SJ, Paterson WG, Meddings JB (2000) Upper gastrointestinal toxicity of alendronate. Am J Gastroenterol 95:634-640
2. Iseri SO, Sener G, Yuksel M, Contuk G, Cetinel S, Gedik N, Yegen BC (2005) Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 187:399-406
3. Blank MA, Ems BL, Gibson GW, Myers WR, Berman SK, Phipps RJ, Smith PN (1997) Nonclinical model for assessing gastric effects of bisphosphonates. Dig Dis Sci 42:281-288
4. Wallace JL, Dicay M, McKnight W, Bastaki S, Blank MA (1999) N-Bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation. Aliment Pharmacol Ther 13:1675-1682
5. Russell RG, Croucher PI, Roger MJ (1999) Bisphosphonates: pharmacology, mechanism of action and clinical uses. Osteoporosis Int 9:S66-S80
6. Lichtenberger LM, Romeo JJ, Gibson GW, Blank MA (2000) Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci 45:1792-1801
7. Luckman SP, Hughes DE, Coxon EP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding protein, including rats. J Bone Miner Res 13:581-589
8. Marshall JK, Rainsford KD, James C, Hunt RH (2000) A randomized controlled trials to assess alendronate-associated injury of the gastrointestinal tract. Aliment Pharmacol Ther 14:1451-1457
9. Kanatsu K, Aihara E, Okayama M, Kato S, Takeuchi K (2004) Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate. J Gastroenterol Hepatol 19:512-520
10. Elliot SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL (1998) Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci 62:77-91
11. Okabe S, Roth JLA, Pfeiffer CJ (1971) A method for experimental, penetrating gastric and duodenal ulcers in rats. Observations on normal healing. Am J Dig Dis 16:277-284
12. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K (1994) Accelerated healing of duodenal ulcers by oral administration of mutein of fibroblast growth factor in rats. Gastroenterology 106:1106-1111
13. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclo-oxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59
14. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502
15. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307:361-368
16. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685
17. Watanabe S, Wang X, Hirose M, Oide H, Kitamura T, Miwa H, Miyazaki A, Sato N (1996) Platelet-derived growth factor accelerated gastric epithelial restoration in a rabbit cultured cell model. Gastroenterology 110:775-779
18. Keisari Y (1992) A colorimetric microtiter assay for the quantitation of cytokine activity on adherent cells in tissue culture. J Immunol Methods 146:151-161
19. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M (1997) Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397
20. Brzozowski T, Konturek PC, Konturek SJ (2001) Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 53:343-353
21. Araki H, Komoike Y, Matsumoto M, Tanaka A, Takeuchi K (2002) Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats. Digestion 66:145-153
22. Amagase K, Yokota M, Tsukimi Y, Okabe S (2003) Characterization of "unhealed gastric ulcers" produced with chronic exposure of acetic acid ulcers to indomethacin in rats. J Physiol Pharmacol 54:349-360
23. Tarnawski A (2005) Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 50:S24-S33
24. Tarnawski A (1993) Cellular mechanisms of gastric ulcer healing. In: Domschke W, Konturek SJ (eds) The stomach. Springer, New York, pp 177-192
25. Tarnawski AS, Jones MK (1998) The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27:S12-S20
26. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R (1995) Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 766:416-430
27. Hase S, Nakazawa S, Tsukamoto Y, Segawa K (1989) Effects of prednisolone and human epidermal growth factor on angiogenesis in granulation tissue of gastric ulcer induced by acetic acid. Digestion 42:135-142
28. Pai R, Szabo IL, Giap AQ, Kawanaka H, Tarnawski AS (2001) Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signaling. Life Sci 69:3055-3071
29. Szabo S, Folkman J, Vincze A, Sandor ZS, Gombos Z (1997) Modulation of vascular factors by VEGF/VPF (vascular endothelial cell growth factor/vascular permeability factor) is sufficient for chronic ulcer healing and acute gastroprotection. Gastroenterology 112:A303
30. Szabo S, Vincze A, Sandor ZS, Gombos Z (1998) Vascular approach to gastroduodenal ulceration: new studies with endothelins and VEGF. Dig Dis Sci 43:40S-45S
31. Ernst H, Konturek PC, Hahn EG, Stosiek HP, Brzozowski T, Konturek SJ (2001) Effect of local injection with basic fibroblast growth factor (BFGF) and neutralizing antibody to BFGF on gastric ulcer healing, gastric secretion, angiogenesis and gastric blood flow. J Physiol Pharmacol 52:377-390
32. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, Futagami S, Miyake K, Gudis K, Mizokami Y, Matsuoka T, Sakamoto C (2004) Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol 287:G444-G451
33. Tarnawski A (2000) Molecular mechanism of ulcer healing. Drug News Perspect 158-168
34. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK (1999) The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 103:R31-R38
35. Halter F, Barbezat GO, Van Hoorn-Hickman R, Van Hoorn WA (1980) Healing dynamics of traumatic gastric mucosal defects in normal and hyperacid stomach. Dig Dis Sci 25:916-920
36. Wang JY, Nagai H, Okabe S (1990) Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol 54:82-85
37. Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y (1989) Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 248:806-815
38. Blank MA, Ems BL, Gibson GW, Myers WR, Berman SK, Phipps RJ, Smith PN (1997) Nonclinical model for assessing gastric effects of bisphosphonates. Dig Dis Sci 42:281-288